California 2019-2020 Regular Session

California Assembly Bill AB2077

Introduced
2/5/20  
Introduced
2/5/20  
Refer
2/27/20  
Report Pass
5/19/20  
Report Pass
5/19/20  
Refer
5/21/20  
Refer
5/21/20  
Report Pass
6/2/20  
Engrossed
6/8/20  
Engrossed
6/8/20  
Refer
6/9/20  
Refer
6/9/20  
Refer
6/23/20  
Refer
6/23/20  
Report Pass
8/1/20  
Report Pass
8/1/20  
Refer
8/1/20  
Refer
8/1/20  
Enrolled
8/29/20  
Enrolled
8/29/20  
Chaptered
9/29/20  
Chaptered
9/29/20  
Passed
9/29/20  

Caption

Hypodermic needles and syringes.

Impact

The enactment of AB 2077 is likely to significantly impact public health strategies in California. By removing barriers to access hypodermic needles, the bill aims to promote responsible usage and harm reduction techniques among individuals who may otherwise be deterred from obtaining these materials due to legal constraints. Furthermore, the bill emphasizes the importance of safe disposal of needles and syringes to prevent community safety hazards, mandating pharmacies and exchange programs to educate consumers on proper disposal practices. These changes reflect a shift towards more compassionate approaches to drug use and health management in the community.

Summary

Assembly Bill 2077, introduced by Ting, addresses the regulation of hypodermic needles and syringes in California. The bill seeks to modernize existing legislation by repealing outdated restrictions that mandated a prescription for buying such items. It extends the authorization for pharmacists to furnish hypodermic needles and syringes without a prescription until January 1, 2026, targeting individuals 18 years and older who require them for personal use. This measure is viewed as a proactive public health initiative aimed at mitigating the spread of bloodborne diseases, such as HIV and viral hepatitis, particularly among injection drug users.

Sentiment

The general sentiment surrounding AB 2077 appears to be positive among public health advocates and legislators concerned about the opioid crisis and bloodborne diseases. Supporters argue that the bill represents a critical evolution in how society approaches and manages drug use and health care access. However, there may be concerns from some segments of society regarding the implications of easier access to needles, owing to prevailing stigmas attached to drug use. Nonetheless, the overarching narrative highlights the necessity of balancing public health needs with concerns about drug-related issues.

Contention

While the bill has garnered support for its public health merits, there are points of contention regarding its potential societal impacts. Critics may express concerns that broader access to hypodermic needles could inadvertently encourage drug use. Additionally, questions could arise about the efficacy of educating users on disposal practices, as safe disposal relies heavily on adherence to recommended procedures by the users. Therefore, the successful implementation of this bill may require ongoing community engagement and education to ensure it meets its public health goals.

Companion Bills

No companion bills found.

Similar Bills

CA AB309

Hypodermic needles and syringes.

CA AB1037

Public health: substance use disorder.

CA AB2136

Controlled substances: analyzing and testing.

CT SB00895

An Act Concerning Changes To Various Pharmacy Statutes.

IL SB3350

FENTANYL TEST STRIPS

CT SB00844

An Act Concerning The Department Of Public Health's Recommendations Regarding Revisions To The Statutes Concerning The Human Immunodeficiency Virus.

IL HB2118

HYPODERMIC SYRINGES-SALE